Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy

Discovery Medicine

Volumn 20, Issue 110, 2015, Pages 207-217

  Yang, Shuai ^a   Li, Hui ^a   Li, Min ^a   Wang, Fang ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKERATIN; DASATINIB; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GLUCOSAMINE; JAGGED1; LY 364947; MICRORNA; MICRORNA 204; MICRORNA 29B; P CADHERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN ZO1; SMAD7 PROTEIN; THROMBIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; VEMENTIN; TRANSCRIPTION FACTOR;

ARTICLE; BRUCH MEMBRANE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; INTRACELLULAR SIGNALING; MICROVILLUS; MOLECULARLY TARGETED THERAPY; MYOFIBROBLAST; NONHUMAN; PIGMENT CELL; PIGMENT EPITHELIUM; VITREORETINOPATHY; BIOLOGICAL MODEL; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; VITREORETINOPATHY, PROLIFERATIVE;

EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84947316572     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. Adijanto J, Castorino JJ, Wang ZX, Maminishkis A, Grunwald GB, Philp NJ. Microphthalmia-associated transcription factor (MITF) promotes differentiation of human retinal pigment epithelium (RPE) by regulating microRNAs-204/211 expression. J Biol Chem 287(24):20491-20503, 2012.
2. Asaria RH, Kon CH, Bunce C, Sethi CS, Limb GA, Khaw PT, Aylward GW, Charteris DG. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol 88(11):1439-1442, 2004.
3. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132(14):3151-3161, 2005.
4. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136(2):215-233, 2009.
5. Bastiaans J, Van Meurs JC, Mulder VC, Nagtzaam NM, Smits-Te Nijenhuis M, Dufour-Van Den Goorbergh DC, Van Hagen PM, Hooijkaas H, Dik WA. The role of thrombin in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 55(7):4659-4666, 2014.
6. Bastiaans J, Van Meurs JC, Van Holten-Neelen C, Nagtzaam NM, Van Hagen PM, Chambers RC, Hooijkaas H, Dik WA. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling. Invest Ophthalmol Vis Sci 54(13):8306-8314, 2013a
7. Bastiaans J, Van Meurs JC, Van Holten-Neelen C, Nijenhuis MS, Kolijn-Couwenberg MJ, Van Hagen PM, Kuijpers RW, Hooijkaas H, Dik WA. Factor Xa and thrombin stimulate proinflammatory and profibrotic mediator production by retinal pigment epithelial cells: a role in vitreoretinal disorders? Graefes Arch Clin Exp Ophthalmol 251(7):1723-1733, 2013b
8. Baudouin C, Fredj-Reygrobellet D, Brignole F, Negre F, Lapalus P, Gastaud P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res 25(1):52-59, 1993.
9. Bian ZM, Elner SG, Elner VM. Thrombin-induced VEGF expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 48(6):2738-2746, 2007.
10. Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 41(8):2336-2342, 2000.
11. Cardillo JA, Stout JT, Labree L, Azen SP, Omphroy L, Cui JZ, Kimura H, Hinton DR, Ryan SJ. Post-traumatic Proliferative Vitreoretinopathy: The Epidemiologfic Profile, Onset, Risk Factors, and Visual Outcome. Ophthalmology 104(7):1166-1173, 1997.
12. Casaroli-Marano RP, Pagan R, Vilaro S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 40(9):2062-2072, 1999.
13. Cassidy L, Barry P, Shaw C, Duffy J, Kennedy S. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82(2):181-185, 1998.
14. Chen HC, Zhu YT, Chen SY, Tseng SC. Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition. Lab Invest 92(5):676-687, 2012.
15. Chen X, Xiao W, Liu X, Zeng M, Luo L, Wu M, Ye S, Liu Y. Blockade of Jagged/Notch pathway abrogates transforming growth factor beta2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. Curr Mol Med 14(4):523-534, 2014a
16. Chen X, Xiao W, Wang W, Luo L, Ye S, Liu Y. The complex interplay between ERK1/2, TGFbeta/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells. PLoS One 9(5):e96365, 2014b
17. Chen X, Ye S, Xiao W, Luo L, Liu Y. Differentially expressed microRNAs in TGFbeta2-induced epithelial-mesenchymal transition in retinal pigment epithelium cells. Int J Mol Med 33(5):1195-1200, 2014
18. Cheng HC, Ho TC, Chen SL, Lai HY, Hong KF, Tsao YP. Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells. Mol Vis 14:95-104, 2008.
19. Chiba C. The retinal pigment epithelium: an important player of retinal disorders and regeneration. Exp Eye Res 123:107-114, 2014.
20. Choi K, Lee K, Ryu SW, Im M, Kook KH, Choi C. Pirfenidone inhibits transforming growth factor-beta1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19. Mol Vis 18:1010-1020, 2012.
21. Connor TB, Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, De Bustros S, Enger C, Kato H, Lansing M, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 83(5):1661-1666, 1989.
22. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 407(6801):258-264, 2000.
23. Cui J, Lei H, Samad A, Basavanthappa S, Maberley D, Matsubara J, Kazlauskas A. PDGF receptors are activated in human epiretinal membranes. Exp Eye Res 88(3):438-444, 2009.
24. Cui JZ, Chiu A, Maberley D, Ma P, Samad A, Matsubara JA. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy. Eye (Lond) 21(2):200-208, 2007.
25. Dvashi Z, Goldberg M, Adir O, Shapira M, Pollack A. TGF-beta1 Induced Transdifferentiation of RPE Cells is Mediated by TAK1. PLoS One 10(4):e0122229, 2015.
26. Feist RM, Jr, King JL, Morris R, Witherspoon CD, Guidry C. Myofibroblast and extracellular matrix origins in proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 252(2):347-357, 2014.
27. Feng XH, Derynck R. Specificity and versatility in TGF-ß signaling through Smads. Annu Rev Cell Dev Biol 21:659-693, 2005.
28. Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15(4):197-204, 2004.
29. Gamulescu MA, Chen Y, He S, Spee C, Jin M, Ryan SJ, Hinton DR. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res 83(1):212-222, 2006.
30. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 36(2):391-405, 1995.
31. Hatanaka H, Koizumi N, Okumura N, Kay EP, Mizuhara E, Hamuro J, Kinoshita S. Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-beta are prevented by PPAR-gamma agonists. Invest Ophthalmol Vis Sci 53(11):6955-6963, 2012.
32. He S, Chen Y, Khankan R, Barron E, Burton R, Zhu D, Ryan SJ, Oliver N, Hinton DR. Connective tissue growth factor as a mediator of intraocular fibrosis. Invest Ophthalmol Vis Sci 49(9):4078-4088, 2008.
33. He S, Kumar SR, Zhou P, Krasnoperov V, Ryan SJ, Gill PS, Hinton DR. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci 51(1):543-552, 2010.
34. Hoerster R, Muether PS, Vierkotten S, Hermann MM, Kirchhof B, Fauser S. Upregulation of TGF-ss1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition. Graefes Arch Clin Exp Ophthalmol 252(1):11-16, 2014.
35. Huang L, Xu Y, Yu W, Li Y, Chu L, Dong J, Li X. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 51(6):3193-3204, 2010.
36. Huang X, Wei Y, Ma H, Zhang S. Vitreous-induced cytoskeletal rearrangements via the Rac1 GTPase-dependent signaling pathway in human retinal pigment epithelial cells. Biochem Biophys Res Commun 419(2):395-400, 2012.
37. Kane R, Stevenson L, Godson C, Stitt AW, O'brien C. Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose. Br J Ophthalmol 89(12):1638-1642, 2005.
38. Khankan R, Oliver N, He S, Ryan SJ, Hinton DR. Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFbeta2 and its receptor TGFbetaRII. Invest Ophthalmol Vis Sci 52(8):5068-5078, 2011.
39. Kim IK, Arroyo JG. Mechanisms in proliferative vitreoretinopathy. Ophthalmol Clin North Am 15(1):81-86, 2002.
40. Kimoto K, Nakatsuka K, Matsuo N, Yoshioka H. p38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19. Invest Ophthalmol Vis Sci 45(7):2431-2437, 2004.
41. Kimura K, Orita T, Fujitsu Y, Liu Y, Wakuta M, Morishige N, Suzuki K, Sonoda KH. Inhibition by female sex hormones of collagen gel contraction mediated by retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 55(4):2621-2630, 2014.
42. Kita T, Hata Y, Arita R, Kawahara S, Miura M, Nakao S, Mochizuki Y, Enaida H, Goto Y, Shimokawa H. Role of TGF-ß in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci U S A 105(45):17504-17509, 2008.
43. Kita T, Hata Y, Kano K, Miura M, Nakao S, Noda Y, Shimokawa H, Ishibashi T. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes 56(1):231-238, 2007.
44. Kon CH, Occleston NL, Aylward GW, Khaw PT. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 40(3):705-712, 1999.
45. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178-196, 2014.
46. Lee H, O'meara SJ, O'brien C, Kane R. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 48(9):4291-4299, 2007.
47. Lei H, Hovland P, Velez G, Haran A, Gilbertson D, Hirose T, Kazlauskas A. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 48(5):2335-2342, 2007.
48. Lei H, Rheaume MA, Kazlauskas A. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. Exp Eye Res 90(3):376-381, 2010a.
49. Lei H, Rheaume MA, Velez G, Mukai S, Kazlauskas A. Expression of PDGFRalpha is a determinant of the PVR potential of ARPE19 cells. Invest Ophthalmol Vis Sci 52(9):5016-5021, 2011a.
50. Lei H, Velez G, Cui J, Samad A, Maberley D, Matsubara J, Kazlauskas A. N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy. Am J Pathol 177(1):132-140, 2010b.
51. Lei H, Velez G, Kazlauskas A. Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53. Mol Cell Biol 31(9):1788-1799, 2011b.
52. Li H, Li M, Xu D, Zhao C, Liu G, Wang F. Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition. Biochem Biophys Res Commun 446(1):347-351, 2014a.
53. Li H, Wang H, Wang F, Gu Q, Xu X. Snail involves in the transforming growth factor beta1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells. PLoS One 6(8):e23322, 2011.
54. Li M, Li H, Liu X, Xu D, Wang F. MicroRNA-29b regulates TGF-beta1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells by targeting AKT2. Exp Cell Res, 2014b.
55. Liang CM, Tai MC, Chang YH, Chen YH, Chen CL, Lu DW, Chen JT. Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy. Acta Ophthalmol 89(6):e505-514, 2011.
56. Liu P, Wakamiya M, Shea MJ, Albrecht U, Behringer RR, Bradley A. Requirement for Wnt3 in vertebrate axis formation. Nat Genet 22(4):361-365, 1999.
57. Liu Y, Xin Y, Ye F, Wang W, Lu Q, Kaplan HJ, Dean DC. Taz-tead1 links cell-cell contact to zeb1 expression, proliferation, and dedifferentiation in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 51(7):3372-3378, 2010.
58. Liu Y, Ye F, Li Q, Tamiya S, Darling DS, Kaplan HJ, Dean DC. Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology. Invest Ophthalmol Vis Sci 50(11):5080-5088, 2009.
59. Machemer R, Van Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 85(2):181-191, 1978.
60. Massagué J. TGFß signalling in context. Nature reviews Mol Cell Biol 13(10):616-630, 2012.
61. Morescalchi F, Duse S, Gambicorti E, Romano MR, Costagliola C, Semeraro F. Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid. Mediators Inflamm 2013:269787, 2013.
62. Nassar K, Grisanti S, Tura A, Luke J, Luke M, Soliman M, Grisanti S. A TGF-beta receptor 1 inhibitor for prevention of proliferative vitreoretinopathy. Exp Eye Res 123:72-86, 2014.
63. Nassar K, Luke J, Luke M, Kamal M, Abd El-Nabi E, Soliman M, Rohrbach M, Grisanti S. The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Graefes Arch Clin Exp Ophthalmol 249(11):1649-1660, 2011.
64. Oshima Y, Sakamoto T, Hisatomi T, Tsutsumi C, Ueno H, Ishibashi T. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy. Gene Ther 9(18):1214-1220, 2002.
65. Palma-Nicolas JP, Lopez-Colome AM. Thrombin induces slug-mediated E-cadherin transcriptional repression and the parallel up-regulation of N-cadherin by a transcription-independent mechanism in RPE cells. J Cell Physiol 228(3):581-589, 2013.
66. Palma-Nicolas JP, Lopez E, Lopez-Colome AM. PKC isoenzymes differentially modulate the effect of thrombin on MAPK-dependent RPE proliferation. Biosci Rep 28(6):307-317, 2008.
67. Palma-Nicolas JP, Lopez E, Lopez-Colome AM. Thrombin stimulates RPE cell motility by PKC-zeta- and NF-kappaB-dependent gene expression of MCP-1 and CINC-1/GRO chemokines. J Cell Biochem 110(4):948-967, 2010.
68. Parrales A, Lopez E, Lee-Rivera I, Lopez-Colome AM. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation. Cell Signal 25(4):829-838, 2013.
69. Parrales A, Palma-Nicolas JP, Lopez E, Lopez-Colome AM. Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression. J Cell Physiol 222(2):302-312, 2010.
70. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13(4):271-282, 2012.
71. Pastor JC, De La Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 21(1):127-144, 2002.
72. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7(6):415-428, 2007.
73. Pennock S, Haddock LJ, Eliott D, Mukai S, Kazlauskas A. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy? Prog Retin Eye Res 40:16-34, 2014.
74. Pennock S, Kazlauskas A. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses. Mol Cell Biol 32(10):1955-1966, 2012.
75. Pennock S, Rheaume MA, Mukai S, Kazlauskas A. A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy. Am J Pathol 179(6):2931-2940, 2011.
76. Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 35(10):3649-3663, 1994.
77. Ruiz-Loredo AY, Lopez E, Lopez-Colome AM. Thrombin promotes actin stress fiber formation in RPE through Rho/ROCK-mediated MLC phosphorylation. J Cell Physiol 226(2):414-423, 2011.
78. Sadaka A, Giuliari GP. Proliferative vitreoretinopathy: current and emerging treatments. Clin Ophthalmol (Auckland, NZ) 6:1325, 2012.
79. Saika S, Kono-Saika S, Tanaka T, Yamanaka O, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Yoo J, Flanders KC, Roberts AB. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest 84(10):1245-1258, 2004.
80. Saika S, Yamanaka O, Nishikawa-Ishida I, Kitano A, Flanders KC, Okada Y, Ohnishi Y, Nakajima Y, Ikeda K. Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model. Arch Ophthalmol 125(5):647-654, 2007.
81. Saito T, Bunnett NW. Protease-activated receptors. Neuromolecular Med 7(1-2):79-99, 2005.
82. Si Y, Wang J, Guan J, Han Q, Hui Y. Platelet-derived growth factor induced alpha-smooth muscle actin expression by human retinal pigment epithelium cell. J Ocul Pharmacol Ther 29(3):310-318, 2013.
83. Skromne I, Stern CD. Interactions between Wnt and Vg1 signalling pathways initiate primitive streak formation in the chick embryo. Development 128(15):2915-2927, 2001.
84. Stocks SZ, Taylor SM, Shiels IA. Transforming growth factor-ß1 induces a-smooth muscle actin expression and fibronectin synthesis in cultured human retinal pigment epithelial cells. Clin Exp Ophthalmol 29(1):33-37, 2001.
85. Tamiya S, Liu L, Kaplan HJ. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci 51(5):2755-2763, 2010.
86. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890, 2009.
87. Tosi GM, Marigliani D, Romeo N, Toti P. Disease pathways in proliferative vitreoretinopathy: an ongoing challenge. J Cell Physiol 229(11):1577-1583, 2014.
88. Umazume K, Barak Y, Mcdonald K, Liu L, Kaplan HJ, Tamiya S. Proliferative vitreoretinopathy in the Swine-a new model. Invest Ophthalmol Vis Sci 53(8):4910-4916, 2012.
89. Umazume K, Liu L, Scott PA, De Castro JP, Mcdonald K, Kaplan HJ, Tamiya S. Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine. Invest Ophthalmol Vis Sci 54(2):1150-1159, 2013.
90. Umazume K, Tsukahara R, Liu L, Fernandez De Castro JP, Mcdonald K, Kaplan HJ, Tamiya S. Role of retinal pigment epithelial cell beta-catenin signaling in experimental proliferative vitreoretinopathy. Am J Pathol 184(5):1419-1428, 2014.
91. Winkler J, Hoerauf H. TGF-ss and RPE-derived cells in taut subretinal strands from patients with proliferative vitreoretinopathy. Eur J Ophthalmol 21(4):422-426, 2011.
92. Xiao W, Chen X, Liu X, Luo L, Ye S, Liu Y. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. J Cell Mol Med 18(4):646-655, 2014.
93. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, Yang J. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 302(3):F369-379, 2012.
94. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19(2):156-172, 2009.
95. Yang LQ, Lin CR, Liu ZR. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from beta-catenin. Cell 127(1):139-155, 2006.
96. Yokoyama K, Kimoto K, Itoh Y, Nakatsuka K, Matsuo N, Yoshioka H, Kubota T. The PI3K/Akt pathway mediates the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 250(1):15-23, 2012.
97. Yu JW, Duan WJ, Huang XR, Meng XM, Yu XQ, Lan HY. MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis. Lab Invest 94(9):978-990, 2014.
98. Zavadil J, Böttinger EP. TGF-ß and epithelial-to-mesenchymal transitions. Oncogene 24(37):5764-5774, 2005.